Literature DB >> 1356449

Flow cytometric analysis of P-glycoprotein in normal and leukemic cells.

M I Tiirikainen1, M T Syrjälä, S E Jansson, T Krusius.   

Abstract

Classical multidrug resistance is characterized by overexpression of a membrane protein, P-glycoprotein, which acts like a drug-extruding pump, reducing accumulation of cytotoxic drugs inside malignant cells. We have developed a simple method for detecting an intracellular epitope of P-glycoprotein in normal and leukemic cells by the monoclonal antibody JSB-1 and fluorescence-activated flow cytometry. Permeabilization of blood and bone marrow cells in unprocessed samples is achieved by a commercially available red blood cell lysing solution which excellently preserves the light scatter properties of leukocytes. The method is suitable for analyzing samples in clinical routine. Lower than 1% reactivity was seen in the lymphoid gate of normal peripheral blood and bone marrow samples as compared with over 60% of reacting cells in some leukemic samples. Twelve patients with acute de novo leukemia were studied at presentation, 13 patients at a refractory stage, and 28 in remission. There was a positive correlation between the P-glycoprotein and the CD34 expression in acute myelogenous leukemia and an association between the P-glycoprotein expression and the blast count in both acute myelogenous and lymphatic leukemias.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356449     DOI: 10.1007/bf01695811

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  42 in total

1.  Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

Authors:  H Hamada; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Structure and expression of the human MDR (P-glycoprotein) gene family.

Authors:  J E Chin; R Soffir; K E Noonan; K Choi; I B Roninson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

3.  P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma.

Authors:  E Solary; J M Bidan; F Calvo; B Chauffert; D Caillot; F Mugneret; C Gauville; T Tsuruo; P M Carli; H Guy
Journal:  Leukemia       Date:  1991-07       Impact factor: 11.528

4.  MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

Authors:  H Sato; H Preisler; R Day; A Raza; R Larson; G Browman; J Goldberg; R Vogler; H Grunwald; A Gottlieb
Journal:  Br J Haematol       Date:  1990-07       Impact factor: 6.998

5.  Quantitation of mRNA by the kinetic polymerase chain reaction assay: a tool for monitoring P-glycoprotein gene expression.

Authors:  T Hoof; J R Riordan; B Tümmler
Journal:  Anal Biochem       Date:  1991-07       Impact factor: 3.365

6.  Detection of P-glycoprotein in human leukemias using monoclonal antibodies.

Authors:  J Mattern; T Efferth; M Bak; A D Ho; M Volm
Journal:  Blut       Date:  1989-04

7.  Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10)

Authors:  R B Geller; M Zahurak; C A Hurwitz; P J Burke; J E Karp; S Piantadosi; C I Civin
Journal:  Br J Haematol       Date:  1990-11       Impact factor: 6.998

8.  Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis.

Authors:  L Campos; D Guyotat; E Archimbaud; P Calmard-Oriol; T Tsuruo; J Troncy; D Treille; D Fiere
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

9.  Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.

Authors:  H Herweijer; P Sonneveld; F Baas; K Nooter
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

10.  Clinical relevance of immunocytochemical detection of multidrug-resistance-associated P-glycoprotein in hematologic malignancies.

Authors:  P Musto; N Cascavilla; N Di Renzo; S Ladogana; A La Sala; L Melillo; M Nobile; R Matera; G Lombardi; M Carotenuto
Journal:  Tumori       Date:  1990-08-31
View more
  3 in total

Review 1.  Multidrug resistance in cancer chemotherapy.

Authors:  N H Patel; M L Rothenberg
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 2.  P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.

Authors:  S Gupta
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 3.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.